Editas Medicine (EDIT) EBITDA Margin (2015 - 2025)
Editas Medicine (EDIT) reported EBITDA Margin of -315.88% for Q3 2025, up 104711.99 percentage points from -105027.87% a year earlier and up 1073.44 percentage points from the prior quarter.
Powered by 
Analysis
Editas Medicine (EDIT) EBITDA Margin (2015 - 2025) Analysis & Trends
Over the twelve months ended Sep 30, 2025, Editas Medicine's EBITDA Margin came in at -416.09%, down 55.66 percentage points year-over-year; for FY2024, it came in at -759.25%, down 550.50 percentage points from FY2023.
- EBITDA Margin has a five-year change of -86.64 percentage points (FY2019 to FY2024).
- By year, EBITDA Margin came in at -208.75% in FY2023 (+905.36 pp), -1114.11% in FY2022 (-377.94 pp), -736.17% in FY2021 (-591.96 pp) and -144.20% in FY2020 (+528.40 pp).
- Five-year quarterly EBITDA Margin spans a low of -133133.33% in Q3 2022 and a high of -37.40% in Q4 2023.
- Year over year, EBITDA Margin has now increased in each of the last three quarters, with an average year-over-year change of +48.38 percentage points over the last eight quarters.
- The high point for year-over-year EBITDA Margin in five years was Q3 2023 (a gain of 132221.62 percentage points); the low point was Q3 2022 (a drop of 132519.12 percentage points).
- Per Business Quant data, the three quarters before Q3 2025 came in at -1389.32% (Q2 2025), -1593.95% (Q1 2025) and -147.73% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Editas Medicine | 234.09 Mn | -477.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -315.88% |
| Jun 30, 2025 | -1,389.32% |
| Mar 31, 2025 | -1,593.95% |
| Dec 31, 2024 | -147.73% |
| Sep 30, 2024 | -105,027.87% |
| Jun 30, 2024 | -13,739.38% |
| Mar 31, 2024 | -5,778.15% |
| Dec 31, 2023 | -37.40% |
| Sep 30, 2023 | -911.71% |
| Jun 30, 2023 | -1,473.99% |
| Mar 31, 2023 | -501.64% |
| Dec 31, 2022 | -946.59% |
| Sep 30, 2022 | -133,133.33% |
| Jun 30, 2022 | -827.35% |
| Mar 31, 2022 | -726.51% |
| Dec 31, 2021 | -321.21% |
| Sep 30, 2021 | -614.22% |
| Jun 30, 2021 | -14,303.96% |
| Mar 31, 2021 | -857.36% |
| Dec 31, 2020 | -566.14% |
API Access
Editas Medicine EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();